Revolade 25mg - Eltrombopag Tablets

Price 15000.0 INR/ Box

Get a Price/Quote

MOQ : 1 Box

Revolade 25mg - Eltrombopag Tablets Specification

Origin
INDIA

Salt Composition
Eltrombopag Tablets

Indication
Treatment of chronic immune thrombocytopenia (ITP), severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C

Dosage Form
Tablets

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
30 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
Thrombopoietin (TPO) receptor agonist; stimulates platelet production

Storage Instructions
Store below 30 C in a cool, dry place; protect from moisture and light

Shelf Life
24 Months

Revolade 25mg - Eltrombopag Tablets Trade Information

Minimum Order Quantity
1 Box

FOB Port
DELHI

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Boxes Per Month

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
BOX

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

About Revolade 25mg - Eltrombopag Tablets

Revolade 25mg tablet is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets.

Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).

This drug should not be used in individuals with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Revolade 25mg tablets are contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as increased liver enzymes and bilirubin levels indicate.

Using this drug in individuals with severe liver disease can further worsen liver function, so caution is advised. Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).

If you stop taking this tablet, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting. However, blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of this medicine to ensure that your platelet count does not become too high.

Do not take this tablet with dairy products or drinks, as the calcium in these items affects the absorption of the medicine. Use effective birth control during the treatment, and if you become pregnant, you must inform your doctor. Revolade 25mg tablets are not advised for children under one with ITP.

It is also not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anaemia. Tell your doctor if you are taking, have recently taken, or might take other medicines. It includes medicines obtained without a prescription and vitamins.